Thrombotic thrombocytopenic purpura and sporadic hemolytic-uremic syndrome plasmas induce apoptosis in restricted lineages of human microvascular endothelial cells

Blood

Volumn 89, Issue 4, 1997, Pages 1224-1234

  Mitra, Debashis ^b   Jaffe, Eric A ^b   Weksler, Babette ^b   Hajjar, Katherine A ^b   Soderland, Carl ^b   Laurence, Jeffrey ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; PROSTACYCLIN;

ADULT; APOPTOSIS; ARTICLE; CELL ULTRASTRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSIS; FEMALE; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROVASCULATURE; PATHOPHYSIOLOGY; PRESCHOOL CHILD; PRIORITY JOURNAL; THROMBOCYTOPENIC PURPURA; VASCULAR ENDOTHELIUM;

EID: 0031050433     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.4.1224     Document Type: Article

References (51)

1. Ruggenenti P, Remuzzi G: The pathophysiology and management of thrombotic thrombocytopenic purpura. Eur J Hematol 56:191, 1996
2. Neild GH: Hemolytic-uremic syndrome in practice. Lancet 343:398, 1994
3. Murgo AJ: Thrombotic microangiopathy in the cancer patient including those induced by chemotherapeutic agents. Semin Hematol 24:161 1987
4. Heyderman RS, Fitzpatrick MM, Barclay GR: Hemolytic-uremic syndrome. Lancet 343:1042, 1994
5. Matsumae T, Takebayashi S, Naito S: The clinico-pathological characteristics and outcome in hemolytic-uremic syndrome of adults. Clin Nephrol 45:153, 1996
6. Koster FT, Boonpucknavig V, Sujaho S, Gilman RH, Rahaman MM: Renal histopathology in the hemolytic-uremic syndrome following shigellosis. Clin Nephrol 21:126, 1984
7. Moake J: Hemolytic-uremic syndrome: Basic science. Lancet 343:393, 1994
8. Louise CB, Obrig TG: Human renal microvascular endothelial cells as a potential target in the development of the hemolytic urémic syndrome as related to fibrinolysis factor expression, in vitro. Microvase Res 47:377, 1994
9. Lefevre P, George F, Durand JM, Sampol J: Detection of circulating endothelial cells in thrombotic thrombocytopenic purpura. Thromb Haemost 69:522, 1993
10. Arends MJ, Harrison DJ: Novel histopathologic findings in a surviving case of hemolytic urémic syndrome after bone marrow transplantation. Hum Pathol 20:89, 1989
11. Laurence J, Mitra D, Steiner M, Staiano-Coico L, Jaffe E: Plasma from patients with idiopathic and human immunodeficiency virus-associated thrombotic thrombocytopenic purpura induces apoptosis in microvascular endothelial cells. Blood 87:3245, 1996
12. Darzynkiewicz Z, Bruno S, DelBino G, Gorczyca W, Hotzma A, Lassota P, Traganos F: Features of apoptotic cells measured by flow cytometry. Cytometry 13:795, 1992
13. Dean PH, Jett JH: Mathematical analysis of DNA distributions derived from flow cytometry. J Cell Biol 60:523, 1974
14. Clement M-V, Stamenkovic I: Fas and tumor necrosis factor receptor-mediated cell death: Similarities and distinctions. J Exp Med 180:557, 1994
15. Stanger BZ: Looking beneath the surface: the cell death pathway of Fas/APO-1 (CD95). Mol Med 2:7, 1996
16. Alderson MR, Tough TW, Davis-Smith T, Braddy S, Falk B, Schooley KA, Goodwin RG, Smith CA, Ramsdell F, Lynch DH: Fas ligand mediates activation-induced cell death in human T lymphocytes. J Exp Med 181:71, 1995
17. Mitra D, Steiner M, Lynch DH, Staiano-Coico L, Laurence J: HIV-1 upregulates Fas ligand expression in CD4+ T cell in vitro and in vivo: Association with Fas-mediated apoptosis and modulation by aurintricarboxylic acid. Immunology 87:581, 1996
18. Alderson MR, Tough TW, Braddy S: Regulation of apoptosis and T cell activation by Fas-specific mAb. Int Immunol 6:1799, 1994
19. Laurence J, Mitra D, Steiner M, Lynch DH, Siegal FP, Staiano-Coico L: Apoptotic depletion of CD4+ T cells in idiopathic CD4+ T lymphocytopenia. J Clin Invest 97:672, 1996
20. Mitra D, Laurence J: Development of a quantitative RT-PCR for human Fas (CD95) expression. Biotechniques (in press)
21. Mitra D, Sikder SK, Laurence J: Role of glucocorticoid receptor binding sites in the human immunodeficiency virus type 1 long terminal repeat in steroid-mediated suppression of HIV gene expression. Virology 214:512, 1995
22. Meikrantz W, Gisselbrecht S, Tam SW, Schlegel R: Activation of cyclin A-dependent protein kinases during apoptosis. Proc Natl Acad Sci USA 91:3754, 1994
23. Osborne L, Kunkel S, Nabel G: Tumor necrosis factor alpha and IL-I stimulate the HIV enhancer by activation of the nuclear factor κB. Proc Natl Acad Sci USA 86:2336, 1989
24. Hajjar KA, Jacovina AT, Chacko J: An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. J Biol Chem 269:21191, 1994
25. Ridolfi RL, Bell WR: Thrombotic thrombocytopenic purpura. Report of 25 cases and review of the literature. Medicine 60:413, 1981
26. Upadhyaya K, Barwick K, Fishaut M, Kashgarian M, Siegel NJ: The importance of nonrenal involvement in hemolytic-uremic syndrome. Pediatrics 65:115, 1980
27. Moake JL, Byrnes JJ: Thrombotic microangiopathies associated with drugs and bone marrow transplantation. Hematol Oncol Clin North Am 10:485, 1996
28. Mahan JD, McAllister C, Karmali M: Verocytotoxin-1 (VT-1 ) induction of apoptosis in human glomerular capillary endothelial cells (GCEC) in vitro is dependent on cytokines, cell confluence and cell cycle. J Am Soc Nephrol 7:1161, 1996
29. Morel-Maroger L, Kanfer A, Solez K, Sraer J-D, Richet G: Prognostic importance of vascular lesions in acute renal failure with microangiopathic hemolytic anemia (hemolytic-uremic syndrome): Clinicopathologic study in 20 adults. Kidney Int 15:548, 1979
30. Rossi EC: Plasma exchange in the thrombotic microangiopathies, in Rossi EC, Simon TL, Moss GS, Gould SA (eds): Principles of Transfusion Medicine (ed 2). Baltimore, MD, Williams & Wilkins, 1996, p 577
31. Asada Y, Sumiyoshi A, Hayashi T, Suzumiya J, Kaketami K: Immunohistochemistry of vascular lesions in thrombotic thrombocytopenic purpura, with special reference to factor VIII related antigen. Thromb Res 38:469, 1985
32. Robaye B, Masselmans R, Fiers W, Dumont JE, Galand P: Tumor necrosis factor induces apoptosis (programmed cell death) in normal endothelial cells in vitro. Am J Pathol 138:447, 1991
33. Katayama M, Handa M, Araki Y, Ambo H, Kawal Y, Watanabe K, Ikeda Y: Soluble P-selectin is present in normal circulation and its plasma level is elevated in patients with thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Br J Haematol 84:702, 1993
34. Cesarman GM, Guevara CA, Hajjar KA: An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation. J Biol Chem 269:21198, 1994
35. Casciola-Rosen L, Rosen A, Petri M, Schlissel M: Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: Implications for coagulation events and antigenic spread in systemic lupus erythematosus. Proc Natl Acad Sci USA 93:1624, 1996
36. Keusch GT, Acheson DWK, Aaldering L, Erban J, Jacewicz MS: Comparison of the effects of Shiga-like toxin on cytokine-and butyrate-treated human umbilical and saphenous vein endothelial cells. J Infect Dis 173:1164, 1996
37. Zamzami N, Susin SA, Marchetti P, Hirsch T, Gomez-Monterrey I, Castedo M, Kroemer G: Mitochondrial control of nuclear apoptosis. J Exp Med 183:1633, 1996
38. Lynch DH, Ramsdell F, Alderson MR: Fas and FasL in the homeostatic regulation of immune responses. Immunol Today 16:569, 1995
39. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang C-P, Nicholl JK, Sutherland GR, Smith TD, Rauch C, Smith CA, Goodwin RG: Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3:673, 1995
40. King KL, Cidlowski JA: Cell cycle and apoptosis: Common pathways to life and death. J Cell Biochem 58:175, 1995
41. Karsan A, Yee E, Kaushansky K, Harlan JM: Cloning of a human Bcl-2 homologue: Inflammatory cytokines induce human A1 in cultured endothelial cells. Blood 87:3089, 1996
42. Varfolomeev EE, Boldin MP, Goncharov TM, Wallach D: A potential mechanism of *cross-talk* between the p55 tumor necrosis factor receptor and Fas/APO1 : Proteins binding to the death domains of the two receptors also bind to each other. J Exp Med 183:1271, 1996
43. Gervasoni C, Ridolfo AL, Bibi T, Santambrogio S, Lupo A, Bertoli S, Galli M: Thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome in HIV-infected patients. XIth International Conference on AIDS, Vancouver, British Columbia, Canada, July 7-12, 1996. abstr Mo.B.1299
44. Ucar A, Fernandez HF, Byrnes JJ, Lian EC-Y, Harrington WJ Jr: Thrombotic microangiopathy and retroviral infections: A 13-year experience. Am J Hematol 45:304, 1994
45. Muro-Cacho CA, Pantaleo G, Fauci AS: Analysis of apoptosis in lymph nodes of HIV-infected persons. J Immunol 154:5555, 1995
46. Kotler DP, Weaver SC, Terzakis JA: Ultrastructural features of epithelial cell degeneration in rectal crypts of patients with AIDS. Am J Surg Pathol 10:531, 1986
47. Bodi I, Abraham AA, Kimmel PL: Apoptosis in human immunodeficiency virus-associated nephropathy. Am J Kidney Dis 26:286, 1995
48. Shj B, de Girolami U, He J, Lorenzo A, Busciglio J, Gabuzda D: Apoptosis induced by HIV-1 infection of the central nervous system. J Clin Invest 98:1979, 1996
49. Henkart PA: ICE family proteases: Mediators of all apoptotic cell death? Immunity 4:195, 1996
50. Phillips MD, Moake JL, Nolasco L, Turner N: Aurin tricarboxylic acid: A novel inhibitor of the association of von Willebrand factor and platelets. Blood 72:1898, 1988
51. Owens MR, Holme S: Aurin tricarboxylic acid inhibits adhesion of platelets to subendothelium. Thromb Res 81:177, 1996